Are you ready to go to bat against prostate cancer? Grab your blue gear and join us on July 8 at Comerica Park as the Detroit Tigers strike out prostate cancer at Prostate Cancer Awareness Night! 🐯💙 To buy tickets to the game, visit tigers.com/prostate
McLaren Health Care’s Post
More Relevant Posts
-
March is prostate cancer awareness month! Prostate cancer is the second most common cancer in men, but awareness and early detection can make all the difference. We at Life stand together with those who are fighting against prostate cancer. Spread the word and raise awareness. Together we can make a difference. #ProstateCancerAwarenessMonth #ProstateCancer
To view or add a comment, sign in
-
-
Screening is key…
You may know that prostate cancer is one of the most common cancer types in men. What you may not know is that there are several options when it comes to prostate cancer screening, explains urologist Dr. Christian Pavlovich. https://bit.ly/3Pxf1tl
To view or add a comment, sign in
-
Did you know? Lung Cancer accounts for more deaths every year than any other cancer and more than breast, prostate, and colon cancer combined! In honor of World Lung Cancer Day, here are important statistics regarding lung cancer that everyone should know: https://lnkd.in/gR5sFJPn #LungCancer #HealthyLee #WorldLungCancerDay
To view or add a comment, sign in
-
-
The hallmarks of cancer have emerged as an empirical tool for refining the complexity of cancer phenotypes and genotypes into a provisional set of underlying principles. Let’s test your knowledge to see how much you know of the 8 hallmarks of cancer:
To view or add a comment, sign in
-
The HUNT is a lung cancer risk prediction model. Can it be used to predict other types of tobacco related cancers, such as bladder cancer? At ASCO 2023, Oluf D. Røe, Oncologists, revealed that the model has good performance, which may open for future screening for bladder cancer. #Cancer #LungCancer #ASCO2023
To view or add a comment, sign in
-
ZERO Prostate Cancer has endless resources for patients and families affected by #prostatecancer. One of our favorites here at #DendreonPharma that we're sharing during #ProstateCancerAwareness Month is the "Am I At Risk?" quiz. In less than 30 seconds, this quiz will tell you if you're at risk for prostate cancer. Take is now at zerocancer.org/pcam-23 and pass it along to someone you care about. #PCAM23 #EarlyDetectionSavesLives #ZEROProstateCancer
Awareness Month | ZERO Prostate Cancer
zerocancer.org
To view or add a comment, sign in
-
Hello friends, as we know, breast cancer is a life-threatening disease and in our fight against breast cancer, the the best weapon we have is early detection of of this cancer. Know more 👉 Link in comment
To view or add a comment, sign in
-
-
🎗 Arbor Scientia Group recognizes that October is Breast Cancer and Liver Cancer Awareness Month 🎗 Did you know that all cancers share behavioral hallmarks, such as evading apoptosis and proliferating without limitations? Watch the video below to learn more about one of the most common mechanisms cancer cells employ to bypass apoptotic signaling. #BreastCancerAndLiverCancerAwareness
To view or add a comment, sign in
-
If you are interested in advancements in oncology or nanomedicine, you'll find this webinar, in which Dr. Giacomantonio lays out the hypothesis for Sona's new study, fascinating. He posits that if the mouse study is successful, it could show that Sona's developing Targeted Hyperthermia Therapy generates novel cancer antigens, thus potentially facilitating the creation of personalized vaccines. His remarks begin at the 3:45 mark.
Sona Nanotech will study its 'THT' cancer therapy for both efficacy and its ability to generate immune responses in a research study of the concept in three mouse cancer models. Sona CEO, David Regan and CSO, Len Pagliaro PhD discussed the study’s aims and potential implications with principal investigator, Dr. carman giacomantonio MD, MSc., FRCSC, and his colleague, Barry Kennedy PhD, in a recent webinar. Dr. Giacomantonio stated that he is "confident in the proof of concept" for the study, the results for which would support the development of Sona's ‘THT’ therapy and form part of any future regulatory submissions. Watch the webinar replay here: https://lnkd.in/eNxMA3NY #FightCRC #cancerresearch #colorectalcancer #boweldiseases #cancerresearchuk #cancerresearch #stockmarketnews #Cancer #colorectalcancercanada
To view or add a comment, sign in
-